AstraZeneca takes advantage of Tanium’s integrations with Microsoft & ServiceNow

By Tanium

No IT system is an island. That’s why an organization that integrates its applications, data, APIs, and devices can benefit from added efficiency, productivity, and agility.

That’s the case for AstraZeneca. With annual sales of $45.8 billion in 2023, the UK-based pharmaceutical company, formed by the 1999 merger of Astra AB and Zeneca PLC, today has a lot to integrate. That includes more than 89,000 employees operating in more than 100 countries, and some 125,000 endpoint devices ranging from personal laptops to enterprise servers.

Keeping all those endpoint devices running is a big, vital job. “Leadership gauges my success on system availability,” says Jeff Haskill, AstraZeneca’sVP of enterprise technology services. “Can they do their research to developmedicines and reach patients? If we have an outage, the medicine literallystops moving.”

Research forms a huge part of AstraZeneca’s work. The company employsover 13,000 R&D specialists – almost 15% of its total workforce – in five research centers worldwide. R&D investments last year totaled $10.9 billion,
almost a quarter of annual revenue. Looking ahead, AstraZeneca says it intends to develop at least 15 new medicines by 2030.

Download to find out more.

Enter your details to receive the free white paper:

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.